Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1995 Apr 15;310(6985):975–978. doi: 10.1136/bmj.310.6985.975

Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study.

S A Grover 1, I Lowensteyn 1, K L Esrey 1, Y Steinert 1, L Joseph 1, M Abrahamowicz 1
PMCID: PMC2549361  PMID: 7728035

Abstract

OBJECTIVE--To evaluate the ability of doctors in primary care to assess risk patients' risk of coronary heart disease. DESIGN--Questionnaire survey. SETTING--Continuing medical education meetings, Ontario and Quebec, Canada. SUBJECTS--Community based doctors who agreed to enroll in the coronary health assessment study. MAIN OUTCOME MEASURE--Ratings of coronary risk factors and estimates by doctors of relative and absolute coronary risk of two hypothetical patients and the "average" 40 year old Canadian man and 70 year old Canadian woman. RESULTS--253 doctors answered the questionnaire. For 30 year olds the doctors rated cigarette smoking as the most important risk factor and raised serum triglyceride concentrations as the least important; for 70 year old patients they rated diabetes as the most important risk factor and raised serum triglyceride concentrations as the least important. They rated each individual risk factor as significantly less important for 70 year olds than for 30 year olds (all risk factors, P < 0.001). They showed a strong understanding of the relative importance of specific risk factors, and most were confident in their ability to estimate coronary risk. While doctors accurately estimated the relative risk of a specific patient (compared with the average adult) they systematically overestimated the absolute baseline risk of developing coronary disease and the risk reductions associated with specific interventions. CONCLUSIONS--Despite guidelines on targeting patients at high risk of coronary disease accurate assessment of coronary risk remains difficult for many doctors. Additional strategies must be developed to help doctors to assess better their patients' coronary risk.

Full text

PDF
975

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson K. M., Wilson P. W., Odell P. M., Kannel W. B. An updated coronary risk profile. A statement for health professionals. Circulation. 1991 Jan;83(1):356–362. doi: 10.1161/01.cir.83.1.356. [DOI] [PubMed] [Google Scholar]
  2. Dunnigan M. G. The problem with cholesterol. BMJ. 1993 May 22;306(6889):1355–1356. doi: 10.1136/bmj.306.6889.1355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Glantz S. A., Parmley W. W. Passive smoking and heart disease. Epidemiology, physiology, and biochemistry. Circulation. 1991 Jan;83(1):1–12. doi: 10.1161/01.cir.83.1.1. [DOI] [PubMed] [Google Scholar]
  4. Goldman L., Gordon D. J., Rifkind B. M., Hulley S. B., Detsky A. S., Goodman D. W., Kinosian B., Weinstein M. C. Cost and health implications of cholesterol lowering. Circulation. 1992 May;85(5):1960–1968. doi: 10.1161/01.cir.85.5.1960. [DOI] [PubMed] [Google Scholar]
  5. Goldman L., Weinstein M. C., Goldman P. A., Williams L. W. Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA. 1991 Mar 6;265(9):1145–1151. [PubMed] [Google Scholar]
  6. Grover S. A., Abrahamowicz M., Joseph L., Brewer C., Coupal L., Suissa S. The benefits of treating hyperlipidemia to prevent coronary heart disease. Estimating changes in life expectancy and morbidity. JAMA. 1992 Feb 12;267(6):816–822. [PubMed] [Google Scholar]
  7. Grover S. A., Coupal L., Fahkry R., Suissa S. Screening for hypercholesterolemia among Canadians: how much will it cost? CMAJ. 1991 Jan 15;144(2):161–168. [PMC free article] [PubMed] [Google Scholar]
  8. Grover S. A., Gray-Donald K., Joseph L., Abrahamowicz M., Coupal L. Life expectancy following dietary modification or smoking cessation. Estimating the benefits of a prudent lifestyle. Arch Intern Med. 1994 Aug 8;154(15):1697–1704. [PubMed] [Google Scholar]
  9. Grover S. A. Modifying serum lipids to prevent coronary heart disease: do we have a consensus? Cardiovasc Drugs Ther. 1993 Nov;7(5):761–765. doi: 10.1007/BF00878927. [DOI] [PubMed] [Google Scholar]
  10. Grover S. A., Palmer C. S., Coupal L. Serum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohort. Arch Intern Med. 1994 Mar 28;154(6):679–684. [PubMed] [Google Scholar]
  11. Kannel W. B., Castelli W. P., Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med. 1979 Jan;90(1):85–91. doi: 10.7326/0003-4819-90-1-85. [DOI] [PubMed] [Google Scholar]
  12. Kinosian B. P., Eisenberg J. M. Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia. JAMA. 1988 Apr 15;259(15):2249–2254. doi: 10.1001/jama.259.15.2249. [DOI] [PubMed] [Google Scholar]
  13. Langner N. R., Hasselback P. D., Dunkley G. C., Corber S. J. Attitudes and practices of primary care physicians in the management of elevated serum cholesterol levels. CMAJ. 1989 Jul 1;141(1):33–38. [PMC free article] [PubMed] [Google Scholar]
  14. Laupacis A., Sackett D. L., Roberts R. S. Therapeutic priorities of Canadian internists. CMAJ. 1990 Feb 15;142(4):329–333. [PMC free article] [PubMed] [Google Scholar]
  15. Leaverton P. E., Sorlie P. D., Kleinman J. C., Dannenberg A. L., Ingster-Moore L., Kannel W. B., Cornoni-Huntley J. C. Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study. J Chronic Dis. 1987;40(8):775–784. doi: 10.1016/0021-9681(87)90129-9. [DOI] [PubMed] [Google Scholar]
  16. Leon D. A., Thomas P., Hutchings S. Lung cancer among newspaper printers exposed to ink mist: a study of trade union members in Manchester, England. Occup Environ Med. 1994 Feb;51(2):87–94. doi: 10.1136/oem.51.2.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Linton A. L. Cholesterol: consensus and controversy. J Clin Epidemiol. 1990;43(10):1021–1022. doi: 10.1016/0895-4356(90)90146-g. [DOI] [PubMed] [Google Scholar]
  18. Mann K. V., Putnam R. W. Physicians' perceptions of their role in cardiovascular risk reduction. Prev Med. 1989 Jan;18(1):45–58. doi: 10.1016/0091-7435(89)90053-4. [DOI] [PubMed] [Google Scholar]
  19. McBride P. E., Plane M. B., Underbakke G. Hypercholesterolemia: the current educational needs of physicians. Am Heart J. 1992 Mar;123(3):817–824. doi: 10.1016/0002-8703(92)90535-4. [DOI] [PubMed] [Google Scholar]
  20. Nethercott J. R. Dermatitis in the printing industry. Dermatol Clin. 1988 Jan;6(1):61–66. [PubMed] [Google Scholar]
  21. Oliver M. F. Doubts about preventing coronary heart disease. BMJ. 1992 Feb 15;304(6824):393–394. doi: 10.1136/bmj.304.6824.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Oliver M. F. Lowering cholesterol for prevention of coronary heart disease--problems and perspectives. Cardiovasc Drugs Ther. 1993 Nov;7(5):785–788. doi: 10.1007/BF00878931. [DOI] [PubMed] [Google Scholar]
  23. Opie L. H. Cholesterol confusion in primary prevention of coronary artery disease. Cardiovasc Drugs Ther. 1993 Nov;7(5):779–784. doi: 10.1007/BF00878930. [DOI] [PubMed] [Google Scholar]
  24. Oster G., Epstein A. M. Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease. The case of cholestyramine. JAMA. 1987 Nov 6;258(17):2381–2387. [PubMed] [Google Scholar]
  25. Schwartz J. S., Lewis C. E., Clancy C., Kinosian M. S., Radany M. H., Koplan J. P. Internists' practices in health promotion and disease prevention. A survey. Ann Intern Med. 1991 Jan 1;114(1):46–53. doi: 10.7326/0003-4819-114-1-46. [DOI] [PubMed] [Google Scholar]
  26. Smith G. D., Song F., Sheldon T. A. Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ. 1993 May 22;306(6889):1367–1373. doi: 10.1136/bmj.306.6889.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Tannenbaum T. N., Sampalis J. S., Battista R. N., Rosenberg E. R., Joseph L. Early detection and treatment of hyperlipidemia: physician practices in Canada. CMAJ. 1990 Nov 1;143(9):875–881. [PMC free article] [PubMed] [Google Scholar]
  28. Weinstein M. C., Stason W. B. Cost-effectiveness of interventions to prevent or treat coronary heart disease. Annu Rev Public Health. 1985;6:41–63. doi: 10.1146/annurev.pu.06.050185.000353. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES